Drugs News and Research

RSS

Reduce inflammatory reaction by losing weight, says researcher

Researchers have found a possible molecular explanation for why overweight is harmful. This new knowledge may provide new drugs for heart attack, stroke, cancer and chronic intestinal inflammation.

25 Aug 2014

Sanofi, Regeneron present alirocumab Phase 3 trial results at ESC Congress 2014

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that details from four pivotal trials in the alirocumab ODYSSEY clinical program will be presented on Sunday, August 31, during a Hot Line session at ESC Congress 2014 in Barcelona, Spain, the world's largest cardiology meeting.

25 Aug 2014

Seniors are less able to afford prescriptions, study finds

In its first few years, Medicare's Part D prescription drug program helped seniors pay for their medications, but that trend appears to be reversing, researchers found. Meanwhile, drugmakers fight over the rules for naming cheaper versions of biologic drugs.

23 Aug 2014

FDA approves ViiV Healthcare's Triumeq tablets for treatment of HIV-1 infection

ViiV Healthcare announced today that the US Food and Drug Administration has approved Triumeq (abacavir 600mg, dolutegravir 50mg and lamivudine 300mg) tablets for the treatment of HIV-1 infection.

23 Aug 2014

New mouse model to open door to research on epilepsy, Alzheimer's

University of Utah scientists have developed a genetically engineered line of mice that is expected to open the door to new research on epilepsy, Alzheimer's and other diseases.

22 Aug 2014

First Edition: August 22, 2014

Kaiser Health News consumer columnist Michelle Andrews writes: "How much leeway do employers and insurers have in deciding whether they'll cover contraceptives without charge and in determining which methods make the cut? Not much, as it turns out, but that hasn't stopped some from trying. Kaiser Health News readers still write in regularly describing battles they're waging to get the birth control coverage they're entitled to" (Andrews, 8/22).

22 Aug 2014

Viewpoints: 'Raw judicial politics' on health law; Texas abortion trial; suicide and gender

The Affordable Care Act -- Obamacare -- has endured so many near-death experiences that digging into the details of still another effort to demolish it is admittedly not an inviting prospect. (My own reaction, I confess, to hearing some months back about the latest legal challenge -- this one aimed at the supposed effect of a single word in the 900-page statute -- was something along the lines of "wake me when it's over.") But stay with me, because this latest round, catapulted onto the Supreme Court's docket earlier this month by the same forces that brought us the failed Commerce Clause attack two years ago, opens a window on raw judicial politics so extreme that the saga so far would be funny if the potential consequences weren't so serious (Linda Greenhouse, 8/20).

22 Aug 2014

Three commonly used NSAIDs affect cell membranes, produce unwanted side effects

Researchers have discovered that three commonly used nonsteroidal anti-inflammatory drugs, or NSAIDs, alter the activity of enzymes within cell membranes. Their finding suggests that, if taken at higher-than-approved doses and/or for long periods of time, these prescription-level NSAIDs and other drugs that affect the membrane may produce wide-ranging and unwanted side effects.

22 Aug 2014

ESMO announces names of outstanding individuals receiving annual awards

The European Society for Medical Oncology, the leading pan-European organisation representing medical oncologists, announced the names of outstanding individuals receiving the Society's esteemed annual awards, to be presented during the ESMO 2014 Congress, on 26 September, in Madrid.

22 Aug 2014

Longer looks: Falling teen birth rate; the right to pain relief; limiting access to Sovaldi

An infectious disease doctor at Tulane University, [MarkAlain] Dery treats people living with HIV in New Orleans and Baton Rouge, the two largest cities in the southern state of Louisiana, which itself has the fourth-highest rate of HIV in the United States, just behind New York, Florida and Maryland.

22 Aug 2014

Novel "man and machine" decision support system for diagnosing malaria infection

A Finnish-Swedish research group at the Institute for Molecular Medicine Finland (FIMM), University of Helsinki, and Karolinska institutet, Stockholm, has developed a novel "man and machine" decision support system for diagnosing malaria infection.

22 Aug 2014

HGSAS launches new online master's degree

The Higher Learning Commission recently granted approval to launch the new online master's degree offered by the Hazelden Graduate School of Addiction Studies (HGSAS).

22 Aug 2014

Auxilium Pharmaceuticals' CCH drug effective against cellulite in Phase 2a study

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced positive results from a randomized, double-blind Phase 2a study of collagenase clostridium histolyticum (or CCH) for the treatment of edematous fibrosclerotic panniculopathy (EFP), commonly known as cellulite.

21 Aug 2014

NeuroDerm signs definitive investment agreements for $16 million financing round

NeuroDerm Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced that it has signed definitive investment agreements for a $16 million financing round led by certain of its existing investors with the participation of new investors, including The Elias Group.

21 Aug 2014

State highlights: Audit says $93M in Medi-Cal payments could be fraudulent; Mass. insurers press on Medicaid pay

A selection of health policy stories from the District of Columbia, California, Massachusetts and Minnesota. The audit released Tuesday reviewed billing data from July 2008 to December 2013 for Medi-Cal's Drug Treatment program, which reimburses rehabilitation clinics.

21 Aug 2014

Viewpoints: Threat to drug development; GOP's Obamacare criticism tempered; finding doctors for seniors

An invasive species has been introduced into the U.S. health innovation ecosystem, with a growing danger of permanent damage to the development of specialty drugs.

21 Aug 2014

Majority of states not measuring up on legislative solutions that fight cancer, shows report

A majority of states are not measuring up on legislative solutions that prevent and fight cancer, according to a new report released today by the American Cancer Society Cancer Action Network (ACS CAN).

21 Aug 2014

Scientists discover predictive marker to classify breast cancer patients for effective treatment

Scientists have made it easier to predict both breast cancer relapses and responses to chemotherapy, through the identification of a unique gene. The newly found marker could help doctors classify each breast cancer patient and customise a treatment regimen that is more effective.

21 Aug 2014

Walgreens' billion-dollar Medicare-biz forecasting mistake

Also, the Wall Street Journal examines the collapse of the Vascular Biogenics initial public offering. A billion-dollar forecasting error in Walgreen Co.'s Medicare-related business has cost the jobs of two top executives and alarmed big investors.

21 Aug 2014

Insulin can protect cells of pancreas from acute pancreatitis

Scientists from The University of Manchester have discovered that insulin can protect the cells of the pancreas from acute pancreatitis - a disease for which there is currently no treatment.

21 Aug 2014

Drugs News and Research

Reduce inflammatory reaction by losing weight, says researcher

Sanofi, Regeneron present alirocumab Phase 3 trial results at ESC Congress 2014

Seniors are less able to afford prescriptions, study finds

FDA approves ViiV Healthcare's Triumeq tablets for treatment of HIV-1 infection

New mouse model to open door to research on epilepsy, Alzheimer's

First Edition: August 22, 2014

Viewpoints: 'Raw judicial politics' on health law; Texas abortion trial; suicide and gender

Three commonly used NSAIDs affect cell membranes, produce unwanted side effects

ESMO announces names of outstanding individuals receiving annual awards

Longer looks: Falling teen birth rate; the right to pain relief; limiting access to Sovaldi

Novel "man and machine" decision support system for diagnosing malaria infection

HGSAS launches new online master's degree

Auxilium Pharmaceuticals' CCH drug effective against cellulite in Phase 2a study

NeuroDerm signs definitive investment agreements for $16 million financing round

State highlights: Audit says $93M in Medi-Cal payments could be fraudulent; Mass. insurers press on Medicaid pay

Viewpoints: Threat to drug development; GOP's Obamacare criticism tempered; finding doctors for seniors

Majority of states not measuring up on legislative solutions that fight cancer, shows report

Scientists discover predictive marker to classify breast cancer patients for effective treatment

Walgreens' billion-dollar Medicare-biz forecasting mistake

Insulin can protect cells of pancreas from acute pancreatitis

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News